Symptom burden and health-related quality of life six months after hyperbaric oxygen therapy in cancer survivors with pelvic radiation injuries

Grete K Velure, Bernd Müller, May Aa Hauken, Grete K Velure, Bernd Müller, May Aa Hauken

Abstract

Purpose: Late radiation tissue injuries (LRTIs) after treatment for pelvic cancer may impair health related quality of life (HRQoL). Hyperbaric oxygen therapy is an adjuvant therapy for LRTIs, but limited studied. The aim of this study was to explore the development and association between symptoms of LRTI and HRQoL following hyperbaric oxygen treatment.

Methods: A pretest-posttest design was used to evaluate the changes in pelvic LRTIs and HRQoL from baseline (T1), immediately after treatment (T2) and at six-month follow-up (T3). EPIC and EORTC-QLQ-C30 were used to assess LRTIs and HRQoL. Changes were analysed with t-tests, and associations with Pearson's correlation and multiple regression analyses.

Results: Ninety-five participants (mean age 65 years, 52.6% men) were included. Scores for urinary and bowel symptoms, overall HRQoL, all function scales and the symptoms scales sleep, diarrhoea, pain and fatigue were significantly improved six months after treatment (P-range = 0.00-0.04). Changes were present already at T2 and maintained or further improved to T3. Only a weak significant correlation between changes in symptoms and overall HRQoL was found (Pearson r-range 0.20-0.27).

Conclusion: The results indicate improvement of pelvic LRTIs and HRQoL following hyperbaric oxygen therapy, corresponding to minimal or moderate important changes. Cancer survivors with pelvic LRTIs and impaired HRQoL may benefit from undergoing hyperbaric oxygen therapy. Especially the reduced symptom-severity and improved social- and role function can influence daily living positively.

Trial registration: ClinicalTrials.gov: NCT03570229. Released 2. May 2018.

Keywords: Hyperbaric oxygen treatment; Pelvic malignancies; Pelvic radiotherapy; Quality of life; Side effects.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s).

References

    1. Lawrie TA, Green JT, Beresford M, et al. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. 2018;1:12529. doi: 10.1002/14651858.CD012529.
    1. Sipaviciute A, Sileika E, Burneckis A, et al. Late gastrointestinal toxicity after radiotherapy for rectal cancer: a systematic review. Int J Colorectal Dis. 2020 doi: 10.1007/s00384-020-03595-x.
    1. Holch P, Henry AM, Davidson S, et al. Acute and late adverse events associated with radical radiation therapy prostate cancer treatment: a systematic review of clinician and patient toxicity reporting in randomized controlled trials. Int J Radiat Oncol Biol Phys. 2017 doi: 10.1016/j.ijrobp.2016.11.008.
    1. Mamguem Kamga A, Dumas A, Joly F, et al. Long-term gynecological cancer survivors in Côte d’Or: health-related quality of life and living conditions. Oncologist. 2019 doi: 10.1634/theoncologist.2018-0347.
    1. Chung YK, Lee YK, Yoon BH, et al. Pelvic insufficiency fractures in cervical cancer after radiation therapy: a meta-analysis and review. In Vivo. 2021 doi: 10.21873/invivo.12356.
    1. Paquette IM, Vogel JD, Abbas MA, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the treatment of chronic radiation proctitis. Dis Colon Rectum. 2018 doi: 10.1097/dcr.0000000000001209.
    1. Pascoe C, Duncan C, Lamb BW, et al. Current management of radiation cystitis: a review and practical guide to clinical management. BJU Int. 2019 doi: 10.1111/bju.14516.
    1. Oscarsson N, Müller B, Rosén A, et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2–3 trial. Lancet Oncol. 2019 doi: 10.1016/s1470-2045(19)30494-2.
    1. Moon R, editor. Hyperbaric oxygen therapy indications. North Palm Beach: Best Publishing Company; 2019.
    1. Clarke RE, Tenorio LM, Hussey JR, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008 doi: 10.1016/j.ijrobp.2007.12.048.
    1. Jacobsen PB, Jim HSL. Consideration of quality of life in cancer survivorship research. Cancer Epidemiol Biomarkers Prev. 2011 doi: 10.1158/1055-9965.EPI-11-0563.
    1. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003 doi: 10.1016/s0895-4356(03)00044-1.
    1. Davis S. Rehabilitation. The use of theories and models in practice. London: Elsevier Health Sciences; 2006.
    1. Chambers SK, Ng SK, Baade P, et al. Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psychooncology. 2017 doi: 10.1002/pon.4342.
    1. Velure GK, Müller B, and Hauken MA (2022) Symptom burden, psychological distress, and health-related quality of life in cancer survivors with pelvic late radiation tissue injuries. Supp Care in Cancer 30(3):2477–2486. 10.1007/s00520-021-06684-x
    1. Pan YB, Maeda Y, Wilson A, et al. Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review. Acta Oncol. 2018 doi: 10.1080/0284186X.2018.1503713.
    1. Pereira D, Ferreira C, Catarino R, et al. Hyperbaric oxygen for radiation-induced cystitis: a long-term follow-up. Actas Urol Esp (Engl Ed) 2020;44(8):561–567. doi: 10.1016/j.acuro.2020.03.010.
    1. Lauvrak V, Frønsdal KB, Ormstad SS et al (2015) Effectiveness of hyperbaric oxygen therapy in patients with late radiation tissue injury or diabetic foot ulcer. Knowledge Centre for the Health Services at the Norwegian Institute of Public Health (NIPH). Effectiveness of Hyperbaric Oxygen Therapy in patients with Late Radiation Tissue Injury or Diabetic Foot Ulcer - NIPH (). Accessed 20 Jan 2021
    1. Camporesi EM. Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41(3):253–257.
    1. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000 doi: 10.1016/s0090-4295(00)00858-x.
    1. Gil KM, Pugh SL, Klopp AH, et al. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol. 2019 doi: 10.1016/j.ygyno.2019.04.682.
    1. Umbehr MH, Bachmann LM, Poyet C, et al. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation. Health Qual Life Outcomes. 2018 doi: 10.1186/s12955-018-0859-1.
    1. Wei JT. Scoring instructions for the expanded prostate cancer index composite (EPIC), Scoring Instructions for the (). Accessed 23 Nov 2021
    1. Skolarus TA, Dunn RL, Sanda MG, et al. Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology. 2015 doi: 10.1016/j.urology.2014.08.044.
    1. Expanded Prostate Index Composite, Characteristics of EPIC domain-specific summary and subscale scores for 112 controls without prostate cancer. Characteristics of EPIC domain-specific summary and subscale scores on controls without prostate cancer (). Accessed 31 March 2021
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European-Organization-for-Research-and-Treatment-of-Cancer Qlq-C30 - a quality-of-life instrument for use in international clinical-trials in oncology. J Natl Cancer Inst. 1993 doi: 10.1093/jnci/85.5.365.
    1. Fayers P, Aaronson N, Bjordal K et al. EORTC QLQ-C30 scoring manual (ed 3). Brussels, Belgium; Microsoft Word - SCmanual.doc (). Accessed 24 Nov 2021
    1. Scott NW, Fayers P, Aaronson NK et al (2008) EORTC QLQ-C30 reference values manual. Introduction (). Accessed 24 Nov 2021
    1. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998 doi: 10.1200/JCO.1998.16.1.139.
    1. Veierød MB, Lydersen S, Laake P. Medical statistics : in clinical and epidemiological research. Oslo: Gyldendal akademisk; 2012.
    1. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002 doi: 10.1200/JCO.2002.20.2.557.
    1. Akoglu H. User’s guide to correlation coefficients. Turk J Emerg Med. 2018 doi: 10.1016/j.tjem.2018.08.001.
    1. George D, Mallery P. IBM SPSS Statistics 26 step by step: a simple guide and reference. New York: Routledge; 2019.
    1. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. . Accessed 18 Jan 2021
    1. Velure G, Müller B, Hauken MAa. Experiences of patients with pelvic radiation injuries after cancer treatment undergoing hyperbaric oxygen therapy: a phenomenological-hermeneutical study. Nordic J Nurs Res. 2021 doi: 10.1177/2057158521994405.
    1. Waldauf P, Jiroutková K, Krajčová A, et al. Effects of rehabilitation interventions on clinical outcomes in critically ill patients: systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2020 doi: 10.1097/CCM.0000000000004382.
    1. Giesinger JM, Loth FLC, Aaronson NK, et al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol. 2020 doi: 10.1016/j.jclinepi.2019.10.003.
    1. Jette AM. Toward a common language for function, disability and health. Phys Ther. 2006 doi: 10.1093/ptj/86.5.726.
    1. Wellam F, Ko Y, Oliffe JL, et al. Prostate cancer treatment and work: a scoping review. Am J Mens Health. 2020 doi: 10.1177/1557988320979257.
    1. Boelhouwer IG, Vermeer W, van Vuuren T. The associations between late effects of cancer treatment, work ability and job resources: a systematic review. Int Arch Occup Environ Health. 2021 doi: 10.1007/s00420-020-01567-w.
    1. Hellbom M, Bergelt C, Bergenmar M, et al. Cancer rehabilitation: a Nordic and European perspective. Acta Oncol. 2011 doi: 10.3109/0284186X.2010.533194.
    1. Nilsen J, Jensen L, Bohn N et al (2019) Å leve med og etter kreft. En undersøkelse blant kreftpasienter og pårørende i Kreftforeingenes brukerpanel. [To live with and beyond cancer. A study among cancer patients and relatives in the Cancer Society’s user panel]. The Norwegian Cancer Society. Rehabiliteringsrapporten-2018_web.pdf (). Accessed 20 Jan 2021
    1. Kowitt SD, Ellis KR, Carlisle V, et al. Peer support opportunities across the cancer care continuum: a systematic scoping review of recent peer-reviewed literature. Support Care Cancer. 2019 doi: 10.1007/s00520-018-4479-4.
    1. Page AE, Adler NE. Cancer care for the whole patient: meeting psychosocial health needs. Washington: The National Academies Collection; 2008.
    1. Graells-Sans A, Serral G, Puigpinós-Riera R. Social inequalities in quality of life in a cohort of women diagnosed with breast cancer in Barcelona (DAMA Cohort) Cancer Epidemiol. 2018 doi: 10.1016/j.canep.2018.03.007.
    1. Rustøen T. Hope and quality of life, two central issues for cancer patients: a theoretical analysis. Cancer Nurs. 1995;18(5):355–361.
    1. Korstjens I, Mesters I, Gijsen B, et al. Cancer patients’ view on rehabilitation and quality of life: a programme audit. Eur J Cancer Care. 2008 doi: 10.1111/j.1365-2354.2007.00864.x.
    1. Hersch J, Juraskova I, Price M, et al. Psychosocial interventions and quality of life in gynaecological cancer patients: a systematic review: psychosocial interventions in gynaeoncology. Psychooncology. 2009 doi: 10.1002/pon.1443.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe